NASDAQ:ALEC - Alector Stock Price, Forecast & News

Alector's stock was trading at $24.92 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ALEC stock has decreased by 12.2% and is now trading at $21.87. View which stocks have been mosted impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Alector.

Alector is scheduled to release its next quarterly earnings announcement on Monday, May 11th 2020. View our earnings forecast for Alector.

Alector Inc (NASDAQ:ALEC) issued its quarterly earnings data on Tuesday, March, 24th. The company reported ($0.45) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.48) by $0.03. The firm had revenue of $6 million for the quarter, compared to the consensus estimate of $9.60 million. Alector had a negative net margin of 496.65% and a negative return on equity of 45.56%. View Alector's earnings history.

5 analysts have issued 1 year price targets for Alector's shares. Their forecasts range from $28.00 to $28.00. On average, they expect Alector's share price to reach $28.00 in the next year. This suggests a possible upside of 28.0% from the stock's current price. View analysts' price targets for Alector.

Media stories about ALEC stock have trended very negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Alector earned a news impact score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutAlector.

Some companies that are related to Alector include argenx (ARGX), Repligen (RGEN), Acceleron Pharma (XLRN), Spark Therapeutics (ONCE), China Biologic Products (CBPO), Ablynx (ABLYF), Iovance Biotherapeutics (IOVA), Adaptive Biotechnologies (ADPT), Momenta Pharmaceuticals (MNTA), Audentes Therapeutics (BOLD), bluebird bio (BLUE), Crispr Therapeutics (CRSP), Allogene Therapeutics (ALLO), Halozyme Therapeutics (HALO) and Denali Therapeutics (DNLI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Advanced Micro Devices (AMD), AT&T (T), Verizon Communications (VZ), Johnson & Johnson (JNJ), Gossamer Bio (GOSS) and Kaleido Biosciences (KLDO).

(ALEC) raised $177 million in an IPO on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ALEC stock can currently be purchased for approximately $21.87.

Alector has a market capitalization of $1.72 billion and generates $21.22 million in revenue each year. The company earns $-105,390,000.00 in net income (profit) each year or ($1.71) on an earnings per share basis. Alector employs 91 workers across the globe. View additional information about Alector.

The official website for Alector is http://www.alector.com/.

Alector's mailing address is 131 OYSTER POINT BLVD. SUITE 600, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]